In hepatocellular carcinoma, PLA2G7-high macrophages represent a highly immunosuppressive subset that hinders CD8+ T-cell activation, suggesting PLA2G7 as a key factor in tumor immune regulation [23]. The gene discussed is CD8A; the disease is hepatocellular carcinoma.